Web seminar recordings

QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in hematological tumors

December 08, 2016
Hematological malignancies originating from hematopoietic and lymphoid tissue are complex heterogeneous diseases characterized by distinct clinicopathological features and molecular alterations. The heterogeneity of leukemia and lymphoma has presented massive challenges for identifying the appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond standard of care and chemotherapy. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of clinically actionable variants from NGS data in clinical genomics laboratories.

Interested in learning more?

Click here

Related videos

Web seminar recordings

Introduction to CLC Genomics Workbench: A preview - Part 1

10,433 views March 14, 2017

Introduction to CLC Genomics Workbench focused on:Overview of the workbench...

Web seminar recordings

Tips and tricks for performing RNA-seq analyses in IPA

9,751 views August 04, 2016

Learn how to upload and analyse your RNA-Seq data in IPA. Learn more about...

Web seminar recordings

Tips and tricks for performing miRNA analysis in IPA

7,068 views May 27, 2016

Learn about IPA’s extensive microRNA content and how to upload and analyse...

Web seminar recordings

Part IV: Compare your Data to Thousands of Analyses Using IPA Analysis Match

7,011 views April 30, 2018

Learn how to use the new Analysis Match feature to discover other IPA Core...